Matisse Pharmaceuticals is a biotechnology company dedicated to development of pharmaceutical therapies.
Matisse Pharmaceuticals has raised $3.9M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in January 2024.
Matisse Pharmaceuticals's investors include Brightlands Venture Partners, Chemelot Ventures, Limburg Business Development Fund (LBDF).
Matisse Pharmaceuticals is headquartered in Geleen, The Netherlands.
Matisse Pharmaceuticals is a biotechnology company dedicated to development of pharmaceutical therapies.
Matisse Pharmaceuticals is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Matisse Pharmaceuticals — Funding & Investors." VCBacked, January 4, 2024, https://www.vcbacked.co/company/matisse-pharmaceuticals. Accessed August 18, 2026.
VCBacked. (2024). Matisse Pharmaceuticals — Funding & Investors. Retrieved August 18, 2026, from https://www.vcbacked.co/company/matisse-pharmaceuticals
{{cite web |title=Matisse Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/matisse-pharmaceuticals |website=VCBacked |access-date=August 18, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated